Purdue's Bankruptcy Exit Approved by Creditors

Located in Stamford, Connecticut, Purdue Pharma has made strides towards resolving its bankruptcy case.

Creditors have given their approval to Purdue Pharma's strategy for emerging from bankruptcy. This plan involves allocating billions of dollars to support communities and individuals adversely affected by the company’s addictive opioid medications.

This endorsement represents a significant move forward for the company and the Sackler family, its billionaire proprietors, as they work to conclude a protracted six-year legal battle. The litigation aims to deliver restitution to thousands of municipal administrations and around 54,000 individuals supposedly harmed due to Purdue’s involvement in the U.S. opioid crisis.